Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
9.40
+0.08 (0.86%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Teladoc Health Revenue
Teladoc Health had revenue of $2.62B in the twelve months ending March 31, 2024, with 6.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $646.13M with 2.68% year-over-year growth. In the year 2023, Teladoc Health had annual revenue of $2.60B with 8.13% growth.
Revenue (ttm)
$2.62B
Revenue Growth
+6.01%
P/S Ratio
0.61
Revenue / Employee
$467,733
Employees
5,600
Market Cap
1.59B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
Dec 31, 2013 | 19.91M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Harmony Biosciences Holdings | 617.51M |
Veracyte | 375.47M |
Mirum Pharmaceuticals | 224.00M |
Arvinas | 71.30M |
Keros Therapeutics | 234.00K |
TDOC News
- 12 hours ago - July 16, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against TDOC - GlobeNewsWire
- 15 hours ago - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Teladoc Health Inc. - TDOC - PRNewsWire
- 1 day ago - Teladoc Health, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before July 16, 2024 to Discuss Your Rights – TDOC - GlobeNewsWire
- 1 day ago - Lost Money on Teladoc Health, Inc. (TDOC)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - PRNewsWire
- 1 day ago - Shareholders that lost money on Teladoc Health, Inc. (TDOC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More - Accesswire
- 1 day ago - TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - GlobeNewsWire
- 2 days ago - Investors in Teladoc Health, Inc. Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights - TDOC - Accesswire
- 2 days ago - Levi & Korsinsky Notifies Shareholders of Teladoc Health, Inc.(TDOC) of a Class Action Lawsuit and an Upcoming Deadline - Accesswire